These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4278267)

  • 21. Carcinoid tumors: effect on thyroid function.
    Bivens CH; Marecek RL; Feldman JM
    Am J Med Sci; 1973 Dec; 266(6):427-36. PubMed ID: 4129861
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic acidosis in patients with the carcinoid syndrome: treatment with parachlorophenylalanine.
    Feldman JM
    J Surg Oncol; 1982 Apr; 19(4):219-23. PubMed ID: 6176809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carcinoid syndrome. Tryptophan metabolism--pathogenesis of concomitant symptoms--combination of tumours].
    Brune GG; Sill V
    Munch Med Wochenschr; 1972 May; 114(20):973-8. PubMed ID: 4538372
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome.
    Feldman JM
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum growth hormone in patients with carcinoid tumours; basal levels and response to glucose and thyrotrophin releasing hormone.
    Oberg K; Norheim I; Wide L
    Acta Endocrinol (Copenh); 1985 May; 109(1):13-8. PubMed ID: 3923754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of plasma 5-hydroxyindoleacetic acid in carcinoid disease: an alternative to 24-h urine collections?
    Degg TJ; Allen KR; Barth JH
    Ann Clin Biochem; 2000 Sep; 37 ( Pt 5)():724-6. PubMed ID: 11026528
    [No Abstract]   [Full Text] [Related]  

  • 28. [Carcinoid and carcinoid syndrome].
    Vrubel F; Martínek K
    Cesk Gastroenterol Vyz; 1970 Oct; 24(7):286-90. PubMed ID: 5480235
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant argentaffinoma with carcinoid syndrome and hypoglycaemia.
    Adamson AR; Grahame-Smith DG; Bogomoletz V; Maw DS; Rothnie NG
    Br Med J; 1971 Jul; 3(5766):93-4. PubMed ID: 5314568
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine.
    Pussard E; Guigueno N; Adam O; Giudicelli JF
    Clin Chem; 1996 Jul; 42(7):1086-91. PubMed ID: 8674193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptozotocin treatment of metastatic carcinoid tumors.
    Feldman JM; Quickel KE; Marecek RL; Lebovitz HE
    South Med J; 1972 Nov; 65(11):1325-7. PubMed ID: 4263638
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome.
    Antonelli A; Del Guerra P; Fierabracci A; Gori E; Baschieri L
    Br Med J (Clin Res Ed); 1987 Oct; 295(6604):961. PubMed ID: 2445410
    [No Abstract]   [Full Text] [Related]  

  • 33. Carcinoid metastatic to the ovary. A clinocopathologic analysis of 35 cases.
    Robboy SJ; Scully RE; Norris HJ
    Cancer; 1974 Mar; 33(3):798-811. PubMed ID: 4815582
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.
    Feldman JM; O'Dorisio TM
    Am J Med; 1986 Dec; 81(6B):41-8. PubMed ID: 2432780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoid tumours.
    Southwood WF
    Proc R Soc Med; 1969 Apr; 62(4):379-80. PubMed ID: 5307001
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone metastases from bronchial carcinoid tumors. Two case-reports.
    Merle-Vincent F; Chevrel G; Lombard-Bohas C; Felmann C; Meunier PJ
    Rev Rhum Engl Ed; 1999 Jan; 66(1):46-8. PubMed ID: 10036699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
    Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
    Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor].
    Goñi F; Oleaga A; Goñi MJ; Monreal M; Yoldi A; González A; Llorente I; Moncada E
    Rev Clin Esp; 1991 Nov; 189(7):331-4. PubMed ID: 1722585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
    Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.
    Kema IP; Meijer WG; Meiborg G; Ooms B; Willemse PH; de Vries EG
    Clin Chem; 2001 Oct; 47(10):1811-20. PubMed ID: 11568091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.